respectively. ESI-mass spectra were measured on a JEOL JMS-T100TD mass spectrometer. High-resolution mass spectra (HRMS) were measured on a JEOL JMS-T100TD by using polyethyleneglycol (PEG) as an internal standard. Reactions were monitored by silica gel TLC (Merck Silica gel 60 PF 254 ) with visualization of components by UV light (254 nm) or with visual observation of the dye spots. Products were purified on a silica gel column chromatography (Taiko-shoji AP-300S).
1. Synthesis of a series of N-oxide-based fluorescent probes.
CoNox-1
CoNox-1. Coumarin-6H was synthesized as previously described. 1 Coumarin-6H (56 mg, 0.23 mmol) was dissolved in ethyl acetate (10 mL), and then m-CPBA (44 mg, 0.26 mmol) was added at 0 °C. After stirring at room temperature for 2 h, the mixture was filtered by a pad of celite. The filtrate was evaporated, and the residue was purified by silica gel column chromatography (CHCl 3 : MeOH = 6:1 to 4:1) to give CoNox-1 as pale yellow solid (37 mg, 63% 145.8, 144.7, 128.2, 127.4, 119.84, 119.81, 118.2, 67.1, 66.9, 25.7, 20.5, 17.2, 16.4 
Coumarin-6H
AcOEt, rt 2 h, 63%
FluNox-1 and Ac-FluNox-1
FluNox-1. Morpholinorhodol was prepared as previously described. 2 Morpholinorhodol (100 mg, 0.249 mmol) was dissolved in DMF (10 mL). After stirring at 0 °C for 10 min, m-CPBA (46.9 mg, 0.272 mmol) was added. The mixture was stirred at room temperature for 3 h. The mixture was evaporated, and the residue was purified by silica gel column chromatography (CHCl 3 : MeOH = 6:1 to 4:1) to give FluNox-1 (59.1 mg, 57% 155.2, 152.8, 152.2, 151.8, 135.6, 130.2, 129.4, 128.9, 126.2, 124.8, 123.8, 120.8, 115.3, 113.0, 109.9, 109.2, 102.4, 82.3, 66.9, 61.6; HRMS (ESI+) The mixture was evaporated, and the residue was dissolved by a mixed solution of AcOEt (10 mL) and toluene (5 mL), and the solution was washed with HCl (0.1 M, 10 mL). The organic layer was dried over MgSO 4 , and evaporated to give the acetylated rhodol derivative quantitatively. This product was used for the next Noxidation step without further purification. Then, the acetylated rhodol (130 mg, 0.29 mmol) was dissolved in ethyl acetate (10 mL), and m-CBPA (55.6 mg, 0.32 mmol) was added to the mixture at 0 °C. After stirring at room temperature for 2 h, additional portion of m-CPBA (55.6 mg, 0.32 mmol) was added. 8, 168.7, 156.5, 152.5, 152.0, 151.22, 151.20, 135.4, 130.1, 128.9, 128.7, 125.6, 125.2, 123.7, 119.8, 118.0, 116.0, 115.5, 110.5, 110.4, 80.9, 67.5, 67.4, 62.0, 61.9, 20.9 5, 168.4, 153.0, 152.7, 152.3, 151.7, 149.7, 134.8, 129.6, 129.1, 128.8, 127.0, 124.9, 124.2, 117.2, 116.9, 110.1, 108.6, 104.8, 97.6, 83.7, 44.5, 21.2, 12.5 168.9, 152.7, 152.2, 151.9, 151.5, 151.3, 135.5, 130.2, 128.9, 128.5, 126.0, 125.4, 123.9, 119.9, 118.1, 116.7, 116.3, 112.7, 110.6, 81.3, 67.2, 67.1, 21.1, 8.4, 8.3 
EtOAc, rt 1 h, 78%
Ac-FluNox-2
FluNox-2 S5 found : 446.1602.
FluNox-2.
To a solution of Ac-FluNox-2 (61 mg, 0.14 mmol) in MeOH (3 mL) and H 2 O (1 mL) was added K 2 CO 3 (57 mg, 0.41 mmol). The mixture was stirred at room temperature for 1 h. Then, an additional portion of K 2 CO 3 (57 mg, 0.41 mmol) was added to the reaction mixture. After stirring at room temperature for 0.5 h, the reaction mixture was neutralized by addition of 1 M HCl, and then evaporated. The residue was purified by silica gel column chromatography (CHCl 3 : MeOH = 10 : 1) to afford FluNox-2 as a pale orange solid (27 mg, 50% 161.6, 153.9, 153.3, 153.2, 147.7, 136.9, 131.7, 131.1, 130.2, 127.5, 126.1, 125.2, 122.8, 117.3, 114.4, 112.5, 110.5, 103.7, 83.3, 67.8, 8.4 
SiRhoNox-1
SiRhodamine B. SiRhodamine B was prepared according to a modified previous procedure. 4 In brief, to a 15 mL sealable pressure tube charged with a magnetic stir bar were added 3,3'-(dimethylsilanediyl) bis(N,Ndiethylaniline) (654 mg, 1.8 mmol, 1.0 eq.) and 2-formylbenzoic acid (1.4 g, 9.2 mmol, 5.0 eq.). The tube was sealed tightly and heated at 140 °C for 19 h. After cooling to room temperature, the reaction mixture was dissolved in AcOEt (200 mL). The organic phase was washed with saturated NaHCO 3 aq. (50 mL × 2) and brine (50 mL), and dried over MgSO 4 . After evaporation, the residue was purified by silica gel column chromatography (CH 2 Cl 2 : EtOAc = 100: 1) to give SiRhodamine B as a green solid (250 mg, 28%). SiRhoNox-1. To a mixture of SiRhodamine B (300 mg, 0.62 mmol) and NaHCO 3 (104 mg, 1.2 mmol) in EtOAc (15 mL) was slowly added m-CPBA (182 mg, 0.74 mmol, 1.2 eq.) at 0 °C. The mixture was warmed to room temperature, and then stirred for 30 min. Insoluble materials were removed by filtration with a pad of celite, and then the filtrate was evaporated. The residue was purified with silica gel chromatography (CHCl 3 :
AcOEt, rt 0.5 h, 55% 152.5, 148.0, 146.5, 145.2, 138.4, 136.5, 133.5, 128.9, 128.1, 127.3, 126.6, 126.5, 125.8, 124.5, 121.7, 115.6, 112.1, 90.4, 66.5, 66.4, 43.9, 12 
Steady-state absorption and fluorescence spectroscopy
The UV-vis absorption spectra were recorded on an Agilent 8453 photodiode array spectrometer equipped with a UNISOKU thermo-static cell holder (USP-203). Fluorescence spectra were recorded using a JASCO FP6600 with a slit width of 5 nm and 6 nm for excitation and emission, respectively. To reduce fluctuation in the excitation intensity during measurement, the lamp was kept on for 30 min prior to the experiment. The path length was 1 cm with a cell volume of 3.0 mL. Quantum yields were measured in 50 mM HEPES buffer (pH 7.4) by using a Quantaurus-QY absolute photo-luminescence quantum yields measurement system (C11347-01, Hamamatsu Photonics).
For determination of pK a , absorption spectra were measured in 200 mM sodium phosphate buffer adjusted to various pH values. pH profiles at 450 nm (FluNox-1 and FluNox-2) and 575 nm (SiRhoNox-1) were fitted to the equation as follows:
where pK a is the acid dissociation constants of FluNox derivatives: A 0 is the initial absorbance at 450 nm at pH 2.03, A 1 is the maximum absorbance at 450 nm associated with the corresponding pK a values. The pK a value for SiRhoNox-1 could not be calculated because of no pH dependent change in absorbance spectrum of SiRhoNox-1 (see Figure S3 ). 
Product analysis
To a solution of a probe (100 µM) in 50 mM HEPES buffer (pH 7.4) was added a solution of FeSO 4 (final, 1 mM). The mixture was kept for 1 h under an ambient condition. The products were analyzed with LC-MS system (LC-20AD, Shimadzu) equipped with a photodiode-array detector (SPD-M20A, Shimadzu) and an LCMS-IT-TOF mass spectrometer (Shimadzu) and with Waters X-Bridge C 18 column (3.5 µm, 2.1 × 100 mm) eluted with gradient systems consisting of H 2 O/CH 3 CN as described in the caption of Figure S5 . The retention times were compared with those of the parent dyes in 50 mM HEPES buffer (pH 7.4). Assignments of the compounds were based on the observed m/z values at each peak.
Cell culture experiments
Human hepatocellular carcinoma (HepG2) cells were cultured in modified essential medium (MEM, Gibco) containing 10% fetal bovine serum (FBS, Gibco), 1% Antibiotic-Antimycotic (ABAM, Gibco), and 2 mM glutamine at 37 °C in a 5% CO 2 / 95% air incubator. Two days before use, cells (1.0 × 10 5 ) were seeded on Advanced TC glass-bottomed dishes (CELLview TM Cell Culture Dish, Greiner).
Confocal fluorescence imaging experiments
Confocal fluorescence images were acquired with Zeiss LSM700 laser confocal microscopy or Olympus IX83 microscope equipped with a 130 W mercury lump, an EMCCD camera (Hamamatsu Photonics, ImagEM), and a disk scan confocal unit (DSU). Images were obtained with appropriate filter sets for each dye as follows. SiRhoNox-1 (5 µM, from 1 mM stock solution in DMSO) was added. After incubation for 2 h (for CoNox-1) or 1 h (for Ac-FluNox-1 and SiRhoNox-1) at 37 °C, the cells were washed with HBSS (×1), and then imaged.
CoNox
For chelation experiments, 1 mM 2,2'-bipyridyl (Bpy, from 100 mM stock solution in DMSO) was added to the cells simultaneously with the probes. 
Imaging experiments under hypoxia
Hypoxia treatments were performed in a hypoxia chamber (InvivO2 hypoxia workstation, Baker Ruskinn, USA) under control of oxygen concentration (1% or 5%). All the mediums and solvents used for hypoxic treatments were pre-incubated for more than 8 h prior to use in the chamber, and all the treatments with SiRhoNox-1, Bpy, and DPI were performed in the hypoxia chamber. HepG2 cells (8 × 10 4 ) were seeded on each well of Advanced-TC glass bottom dishes. After incubation in MEM (+10% FBS, 2 mM glutamine, and 1% ABAM) for 2 days prior to use, the cells were placed in the hypoxia chamber and incubated for 2, 4, 8, or 12 h under the controlled oxygen concentration of 1% or 5% at 37 °C. For the cell-staining experiments, the cells were washed with HBSS, and then the medium was replaced with new HBSS solution containing 5 µM SiRhoNox-1with or without 1 mM Bpy or DPI (10 or 100 µM, diphenyliodonium chloride). After incubation of the cells in the chamber for 30 min, the cells were washed with HBSS and then imaged. For control experiments (20% O 2 ), the cells were incubated in an incubator (37 °C, 5% CO 2 , 95% air) for the same period, and all the treatments were performed in a standard clean bench.
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Quantification of total intracellular iron by atomic absorption spectrometry
HepG2 cells (1.2 × 10 5 cells) were seeded on a 10 cm dish 2 days prior to use. The cells were cultured under hypoxia (1% O 2 ) as described above for 0, 2, 4, 8, and 12 h. Then, the medium was washed with cold phosphate-buffered saline (PBS, 3 mL × 3). The cells were removed from the dishes by using a scraper, and then the suspension was centrifuged (1,000 rpm, 5 min). The supernatant was carefully removed, and the cells were re-suspended into conc. HNO 3 (100 µL). The suspension was heated to 90 °C for 4 h to dissolve the cell bodies. The lysate was diluted to 2 mL with distilled water. Concentrations of iron in the samples were measured by furnace atomic absorption spectroscopy with a Shimadzu AA-7000 atomic absorption spectrometer. The obtained values (ng/mL) were normalized with the cell numbers (per 10 6 cells).
Total 4 dishes were prepared for each experiment as described above. 3 dishes were used for iron quantification, and the rest was used to calculate the number of cells. To determine the cell numbers, the cells were collected by trypsinization at the same time point with the other 3 dishes, and the number of the cells was counted by a hematocytometer.
Western blotting of HIF-1a and ferritin
HepG2 cells (6.0 × 10 6 cells) were seeded on a 10 cm dish and then incubated at 37 °C for 12 h. The cells were cultured under aerobic or hypoxic (20% or 1% O 2 ) conditions for 2, 4, 8, or 12 h. Then, the cells were collected by cell scraper and lysed by RIPA (radio-immunoprecipitation assay) buffer for 30 min on ice. After centrifugation (14,000 rpm, 4 °C, 10 min) of the cell lysate, the supernatants were applied to SDS-PAGE (10% SDS). Protein concentrations were determined by BCA-assay according to the manufacturer's protocol (ThermoFisher Scientific). The cell extracts (total 100 µg/mL of proteins) were subjected to SDS-PAGE (10% SDS) followed by electrotransfer to a nitrocellulose membrane. Immuno-blotting was performed by using primary antibodies for HIF-1a (1:1000, Sigma-Aldrich), ferritin (1:1000, ab75973, Abcam), and for b-actin 
Preparation and imaging study of spheroids 6
HepG2 cells (1.0 × 10 3 cells/well) were seeded on a PrimeSurface ® 96-well plate (Sumitomo Bakelite Co. Ltd., Japan). After incubation for 5 days in MEM (+10% FBS), the spheroids growing to 500 µm of diameter were picked up and transferred to a new PrimeSruface ® 96-well plate. Then the spheroids were treated with 10 µM
SiRhoNox-1 or 200 µM pimonidazole hydrochloride (Hypoxyprobe, Inc., USA) in MEM (−FBS, 0.5% DMSO) at 37 °C for 2 h. The medium was exchanged to fresh medium (MEM, −FBS), and the spheroids were S10 incubated for further 30 min. Then, the spheroids were fixed by treatment with a mixture of formalin (10%) and sucrose (10%) in water at room temperature for 2 h. After washing with PBS, the spheroids were embedded into optimal cutting temperature (O.C.T.) compound (Sakura Finetek Japan) and frozen at −20 °C overnight.
The embedded spheroids were cut into 7 µm thick slices with a cryostat (Leica). The sections placed on slide glasses without holes in the central area were selected for next step.
For imaging SiRhoNox-1-treated spheroids, the sections were further stained with 0.05% (w/v) DAPI (nuclear staining dye) in 7% FBS/PBS solution at room temperature for 20 min. After washing with PBS (× 5), they were mounted with coverslips using VECTASHIELD mounting medium (Vector Laboratories, USA) as the manufacturer's protocol.
For immuno-staining of pimonidazole, the sections were treated with a solution of 0.5% Triton X-100 in PBS at room temperature for 30 min, washed by PBS twice, incubation in 7% FBS/PBS blocking solution at room temperature for 30 min, and then stained with 2% FITC MAb1 (Hypoxyprobe, Inc., USA), a fluoresceinconjugated antibody for pimonidazole-thiol adducts, in 7% FBS/PBS at room temperature for 1 h. After washing with PBS, the slices were further stained with 0.05% (w/v) DAPI in 7%FBS/PBS solution at room temperature for 20 min, washed with PBS (× 5), and mounted with coverslips using VECTASHIELD mounting medium.
The prepared sections were observed with the confocal microscope (Olympus IX83) with appropriate filters. 2.03, 3.31, 5.32, 6.16, 6.89, 7.94, 8.68, 9.69, and 11.2) 20%B to 90%B over 15min. Total ion mass spectra provided mass peaks at each time point as follows. (a) Quantification of images taken under 1% oxygen (hypoxia+) and 20% oxygen (hypoxia−) (n = 4). (c) Quantification of images taken under 5% oxygen (hypoxia+) and 20% oxygen (hypoxia−) (n = 4). All the images were taken by using a Cy5 filter set as described above. Scale bars indicate 25 µm. Statistical analyses were performed with a Student's t-test. **P < 0.01 (n = 4). Error bars mean ± s.e.m. Figure S11 . Fluorescence response of 2 µM SiRhoNox-1 against nitroreductase (0.8 U/mL) in the presence or absence of 200 µM b-NADPH. All the data were acquired after incubation at 37 °C for 1 h in 50 mM HEPES buffer (pH 7.4). 
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1 H-and 13 C-NMR spectra of newly synthesized compounds
